Page last updated: 2024-08-21

3-hydroxyflavone and Retinal Diseases

3-hydroxyflavone has been researched along with Retinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Armstrong, S; Beausejour, C; Beltran, PJ; Buscarlet, M; Cagnone, G; Chaney, SY; Crespo-Garcia, S; Dasgupta, S; Dejda, A; Dogan, T; Dubrac, A; Fournier, F; Girouard, G; Guber, V; Joyal, JS; Juneau, R; Mallette, FA; Marquess, D; O'Brien, R; Patel, P; Pilon, F; Rao, SR; Ryan, RD; Sapieha, P; Tsuruda, PR; Wilson, AM; Yohn, CB	1

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Retinal Diseases

Article	Year
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition. Cell metabolism, 2021, 04-06, Volume: 33, Issue:4 Topics: Animals; Apoptosis; bcl-X Protein; Cellular Senescence; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Endothelial Cells; Female; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Retinal Diseases; Tacrolimus	2021

Article

Year

Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition.

Cell metabolism, 2021, 04-06, Volume: 33, Issue:4

Topics: Animals; Apoptosis; bcl-X Protein; Cellular Senescence; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Endothelial Cells; Female; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Retinal Diseases; Tacrolimus

2021